Virginie Supervie1, Jean-Paul Viard2, Dominique Costagliola1, Romulus Breban3. 1. Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health INSERM, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health. 2. Sorbonne Paris Cité, Faculté de Médecine, Université Paris Descartes, EA7327 APHP, Centre de Diagnostic et de Thérapeutique, Hôpital de l'Hôtel-Dieu. 3. Unité d'Epidémiologie des Maladies Emergentes, Institut Pasteur, Paris, France.
Abstract
BACKGROUND: Although essential for patient counseling and quality of life of human immunodeficiency virus (HIV)-infected individuals, the risk of HIV transmission during 1 unprotected sex act with an HIV-infected person under combination antiretroviral therapy (cART) remains unknown. METHODS: We reviewed systematically the literature for studies on HIV transmission among heterosexual HIV-serodiscordant couples, where the infected partner was on cART, with regular virological monitoring, reporting on condom use and sexual activity. We used Bayesian statistics to combine data from selected studies, to investigate the per-act risk of HIV transmission through unprotected sex with an HIV-infected person on cART for >6 months. RESULTS: At most, 1 HIV transmission, over an estimated 113 480 sex acts, of which 17% were not condom protected, was reported within 1672 HIV-serodiscordant couples where the index partner had been treated for >6 months. Data were insufficient to determine whether the reported transmission occurred before or after 6 months of cART. We estimated the upper-bound per-act risk of HIV transmission at either 8.7 or 13:100 000, depending on whether the transmission occurred before or after 6 months of cART. These estimates applied whether or not index partners were virally suppressed. Estimating an upper-bound risk <1:100 000 would require observing no HIV transmission while collecting >12 times the available amount of data. CONCLUSIONS: Available data do not support zero risk of HIV transmission under cART. The per-act risk of HIV transmission through unprotected sex with HIV-infected individuals on cART in comprehensive care for >6 months (whether or not virally suppressed) is <13:100 000. Estimating a 10-fold lower upper-bound risk may be unfeasible due to high condom use among HIV-serodiscordant couples in most research studies.
BACKGROUND: Although essential for patient counseling and quality of life of human immunodeficiency virus (HIV)-infected individuals, the risk of HIV transmission during 1 unprotected sex act with an HIV-infectedperson under combination antiretroviral therapy (cART) remains unknown. METHODS: We reviewed systematically the literature for studies on HIV transmission among heterosexual HIV-serodiscordant couples, where the infected partner was on cART, with regular virological monitoring, reporting on condom use and sexual activity. We used Bayesian statistics to combine data from selected studies, to investigate the per-act risk of HIV transmission through unprotected sex with an HIV-infectedperson on cART for >6 months. RESULTS: At most, 1 HIV transmission, over an estimated 113 480 sex acts, of which 17% were not condom protected, was reported within 1672 HIV-serodiscordant couples where the index partner had been treated for >6 months. Data were insufficient to determine whether the reported transmission occurred before or after 6 months of cART. We estimated the upper-bound per-act risk of HIV transmission at either 8.7 or 13:100 000, depending on whether the transmission occurred before or after 6 months of cART. These estimates applied whether or not index partners were virally suppressed. Estimating an upper-bound risk <1:100 000 would require observing no HIV transmission while collecting >12 times the available amount of data. CONCLUSIONS: Available data do not support zero risk of HIV transmission under cART. The per-act risk of HIV transmission through unprotected sex with HIV-infected individuals on cART in comprehensive care for >6 months (whether or not virally suppressed) is <13:100 000. Estimating a 10-fold lower upper-bound risk may be unfeasible due to high condom use among HIV-serodiscordant couples in most research studies.
Authors: Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher Journal: Ann Intern Med Date: 2009-07-20 Impact factor: 25.391
Authors: T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray Journal: N Engl J Med Date: 2000-03-30 Impact factor: 91.245
Authors: Marie-Claude Boily; Rebecca F Baggaley; Lei Wang; Benoit Masse; Richard G White; Richard J Hayes; Michel Alary Journal: Lancet Infect Dis Date: 2009-02 Impact factor: 25.071
Authors: Susan H Eshleman; Sarah E Hudelson; Andrew D Redd; Ronald Swanstrom; San-San Ou; Xinyi Cindy Zhang; Li-Hua Ping; Estelle Piwowar-Manning; Stephen F Porcella; Matthew F Sievers; Craig A Martens; Daniel Bruno; Elena Dukhovlinova; Marybeth McCauley; Theresa Gamble; Jessica M Fogel; Devin Sabin; Thomas C Quinn; Laurence Gunde; Madalitso Maliwichi; Nehemiah Nhando; Victor Akelo; Sikhulile Moyo; Ravindre Panchia; Nagalingeswaran Kumarasamy; Nuntisa Chotirosniramit; Marineide Gonçalves de Melo; Jose Pilotto; Beatriz Grinsztejn; Kenneth Mayer; Ying Q Chen; James P Hughes; Myron S Cohen Journal: J Acquir Immune Defic Syndr Date: 2017-01-01 Impact factor: 3.731
Authors: Jennifer LeMessurier; Gregory Traversy; Olivia Varsaneux; Makenzie Weekes; Marc T Avey; Oscar Niragira; Robert Gervais; Gordon Guyatt; Rachel Rodin Journal: CMAJ Date: 2018-11-19 Impact factor: 8.262
Authors: Joseph B Sempa; Jonathan Dushoff; Michael J Daniels; Barbara Castelnuovo; Agnes N Kiragga; Martin Nieuwoudt; Steven E Bellan Journal: Am J Epidemiol Date: 2016-05-04 Impact factor: 4.897
Authors: A Hahn; R Hinz; T Meyer; U Loderstädt; O Herchenröder; C G Meyer; N G Schwarz; H Frickmann Journal: Epidemiol Infect Date: 2018-04-15 Impact factor: 4.434
Authors: Nicholas I Paton; Wolfgang Stöhr; Alejandro Arenas-Pinto; Martin Fisher; Ian Williams; Margaret Johnson; Chloe Orkin; Fabian Chen; Vincent Lee; Alan Winston; Mark Gompels; Julie Fox; Karen Scott; David T Dunn Journal: Lancet HIV Date: 2015-09-14 Impact factor: 12.767
Authors: Ji Su Seong; Hoon Kim; Wan Beom Park; Nam Joong Kim; Myoung Don Oh; Sung Sup Park; Joong Shin Park; Young Min Choi Journal: J Korean Med Sci Date: 2020-06-29 Impact factor: 2.153
Authors: Andrew Mujugira; Connie Celum; Robert W Coombs; James D Campbell; Patrick Ndase; Allan Ronald; Edwin Were; Elizabeth A Bukusi; Nelly Mugo; James Kiarie; Jared M Baeten Journal: J Acquir Immune Defic Syndr Date: 2016-08-15 Impact factor: 3.731